New agents and combinations in the treatment of bronchogenic carcinoma

G. P. Bodey, J. A. Gottlieb, R. Livingston, E. Frei

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Phase I and II studies have been conducted with various combinations of vincristine, bleomycin, methyl-CCNU, and cyclophosphamide in the treatment of bronchogenic carcinoma. Although bleomycin alone was not very active, the combination of vincristine and bleomycin produced three partial responses in 12 patients. Methyl-CCNU alone produced four partial responses in 16 patients, whereas the combination of methyl-CCNU and cyclophosphamide produced three partial responses in ten patients. Preliminary studies have been initiated with the four drugs in combination and five of 13 patients have achieved partial responses. Major toxic effects have included nausea, vomiting, skin changes, neuropathy, and myelosuppression. Further studies with this combination are warranted.

Original languageEnglish (US)
Pages (from-to)III
JournalCANCER CHEMOTHER.REP.
Volume4
Issue number2
StatePublished - Dec 1 1973

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'New agents and combinations in the treatment of bronchogenic carcinoma'. Together they form a unique fingerprint.

  • Cite this